Results 41 to 50 of about 72,557 (166)

Bionanomedicine: A “Panacea” In Medicine?

Makara Journal of Health Research, 2017
Recent advances in nanotechnology, biotechnology, bioinformatics, and materials science have prompted novel developments in the field of nanomedicine. Enhancements in the theranostics, computational information, and management of diseases/disorders are ...
Dito Anurogo, Arli A. Parikesit, Taruna Ikrar   +2 more
doaj   +1 more source

Extracellular Vesicles as Drug Delivery Systems in Cancer

Pharmaceutics, 2020
Within tumors, Cancer Stem Cell (CSC) subpopulation has an important role in maintaining growth and dissemination while preserving high resistance against current treatments.
Laia Hernandez-Oller, Joaquin Seras-Franzoso, Fernanda Andrade, Diana Rafael, Ibane Abasolo, Petra Gener, Simo Schwartz Jr.   +6 more
doaj   +1 more source

Gb3/cd77 Is a Predictive Marker and Promising Therapeutic Target for Head and Neck Cancer

Biomedicines, 2022
Head and neck squamous cell carcinoma is the sixth leading cancer in the world. This cancer is difficult to treat and is characterized by recurrences that are often fatal.
Lorena García-Hevia, Débora Muñoz-Guerra, Íñigo Casafont, Carmelo Morales-Angulo, Victor J. Ovejero, David Lobo, Mónica L. Fanarraga   +6 more
doaj   +1 more source

Progress and application of intelligent nanomedicine in urinary system tumors

Journal of Pharmaceutical Analysis
Urinary system tumors include malignancies of the bladder, kidney, and prostate, and present considerable challenges in diagnosis and treatment. The conventional therapeutic approaches against urinary tumors are limited by the lack of targeted drug ...
Yingming Xiao, Lei Zhong, Jinpeng Liu, Li Chen, Yi Wu, Ge Li   +5 more
doaj   +1 more source

Microneedle-mediated nanomedicine to enhance therapeutic and diagnostic efficacy

Nano Convergence
Nanomedicine has been extensively explored for therapeutic and diagnostic applications in recent years, owing to its numerous advantages such as controlled release, targeted delivery, and efficient protection of encapsulated agents.
Yuyang Zuo, Rujie Sun, Nuala Del Piccolo, Molly M. Stevens   +3 more
doaj   +1 more source

Reflections on Emerging Technologies in Nanomedicine

Erciyes Medical Journal, 2020
Nanomedicine technologies seem to play an increasing role in modern medicine. Although there are many challenges, it is important to consider emerging technologies that may impact nanomedicine. To establish a rational basis for such consideration in this
Munis Dündar, Adam Mechler, Jean-pierre Alcaraz, Gary Henehan, Satya Prakash, Ratnesh Lal, Donald Martin   +6 more
doaj   +1 more source

Nanomedicine in GI

American Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
Recent advances in nanotechnology offer new hope for disease detection, prevention, and treatment. Nanomedicine is a rapidly evolving field wherein targeted therapeutic approaches using nanotechnology based on the pathophysiology of gastrointestinal diseases are being developed.
Laroui, Hamed, Wilson, David, Dalmasso, Guillaume, Salaita, Khalid, Murthy, Niren, Sitaraman, Shanthi, Merlin, Didier   +6 more
openaire   +4 more sources

Environmental Barriers To Transfer And Commercialize Nanomedicine Research Results In Iran: A Qualitative Research

پیاورد سلامت, 2014
Background and Aim: Nanomedicine is growing very fast. Transfer and commercialization of research results in Nanomedicine is a missing link between technology and market. This is affected by some factors which are barriers to commercialization.
Seyed Reza Hejazi, Payam Mansoor Hosseini   +1 more
doaj   +2 more sources

Recent Advances in Nanomedicine for the Diagnosis and Therapy of Liver Fibrosis

Nanomaterials, 2020
Liver fibrosis, a reversible pathological process of inflammation and fiber deposition caused by chronic liver injury and can cause severe health complications, including liver failure, liver cirrhosis, and liver cancer.
Xue Bai, Gaoxing Su, Shumei Zhai
doaj   +1 more source

Author Correction: Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy

Nature Communications, 2020
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Anna Galstyan, Janet L. Markman, Ekaterina S. Shatalova, Antonella Chiechi, Alan J. Korman, Rameshwar Patil, Dmytro Klymyshyn, Warren G. Tourtellotte, Liron L. Israel, Oliver Braubach, Vladimir A. Ljubimov, Leila A. Mashouf, Arshia Ramesh, Zachary B. Grodzinski, Manuel L. Penichet, Keith L. Black, Eggehard Holler, Tao Sun, Hui Ding, Alexander V. Ljubimov, Julia Y. Ljubimova   +20 more
doaj   +1 more source